Development of a Sustained-Release Oral Tablet of Tyrosine Kinase Inhibitor Imatinib Using Full Factorial Design. Dhaka Univ. J. Pharm. Sci 2024, 23 (2), 135-143. https://doi.org/10.3329/dujps.v23i2.78571.